Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06645002 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effect of Stevia Leave Powder on Blood Glucose and Lipid Profile of Diabetic Patients

Study acronym: Diabetes
StatusUnknown
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated October 16, 2024 (before its estimated November 22, 2024 completion). Its status may not reflect the trial's current state.

Record History

  1. Changed Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Enrolling by Invitation
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
University of Lahore
103 trials monitored
See 3 trials at risk
Diabetes
5,087 trials monitored
See 222 trials at risk
The goal of this clinical trial is to know if stevia leave powder capsule (1000 mg/day) will work to treat diabetes in participants. The main objectives it aims to answer are: Does stevia decrease the blood glucose level in diabetic subjects that will use stevia powder capsule? Does stevia play its role in blood lipid profile in diabetic subjects that will use stevia powder capsule? The purpose of the study to see the impact of stevia in short (7 days) and long-term treatments (60 days) in diabetic subjects and compare the results Diabetic subjects will: Take stevia powder capsule every day for 7 days in short term study Take stevia powder capsule every day for 60 days in long term study Check the biochemical assessment including blood glucose and lipid profile tests at 0 and 7th days in short term study Check the biochemical assessment including blood glucose and lipid profile tests at 0 and 30 and 60th days in long term study Keep a record of all the tests for comparison
Trial Details
NCT Number NCT06645002
Lead Sponsor University of Lahore
Collaborators: Allied Hospital Faisalabad
Conditions
(from sponsor)		 Diabetes
Related terms Diabetes Mellitus
Enrollment 144 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov